Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Censoring Survival Data01:09

Censoring Survival Data

456
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
456
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

322
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
322
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

660
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
660
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

495
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
495
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

491
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
491
Survival Tree01:19

Survival Tree

333
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
333

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Soft Bayesian Additive Regression Trees (SBART) for correlated survey response with non-Gaussian error.

Journal of nonparametric statistics·2026
Same author

Identification of a robust metabolic signature associated with hospital-acquired pneumonia and response to interferon-gamma treatment in critically ill patients.

Critical care (London, England)·2026
Same author

A gene-expression module identifies circulating immune cells with enhanced recruitment to sites of inflammation.

iScience·2026
Same author

Macrophage MR1 antigen presentation promotes MAIT cell immunity and lung microbiota modulation.

Science (New York, N.Y.)·2025
Same author

A practical overview and statistical analysis of interval-censored data in cancer.

Cancer communications (London, England)·2025
Same author

Bayesian monotone single-index quantile regression model with bounded response and misaligned functional covariates.

Biometrics·2025

Related Experiment Video

Updated: Dec 24, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K

Bayesian analysis of survival data with missing censoring indicators.

Naomi C Brownstein1,2,3,4, Veronica Bunn4, Luis M Castro5,6,7

  • 1Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida.

Biometrics
|April 14, 2020
PubMed
Summary

This study introduces a Bayesian method to handle missing data in clinical trials, improving survival analysis accuracy. The new approach enhances the reliability of results from large studies with incomplete censoring information.

Keywords:
interim event adjudicationmissing dataproportional hazardssemiparametric Bayestime-to-event

More Related Videos

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

8.7K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.4K

Related Experiment Videos

Last Updated: Dec 24, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K
Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

8.7K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.4K

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Survival Analysis

Background:

  • Large clinical studies often face challenges in collecting complete data, particularly regarding the precise timing of events.
  • Missing censoring indicators in survival data can arise when physical examinations are impractical at the final monitoring time.
  • The probability of missing data may be influenced by monitoring time and patient covariates.

Purpose of the Study:

  • To develop a robust statistical method for analyzing survival data with missing censoring indicators.
  • To estimate regression parameters within the Cox proportional hazards model framework.
  • To address the complexities introduced by non-random missingness in clinical trial data.

Main Methods:

  • A fully Bayesian semi-parametric approach was employed for survival data analysis.
  • The method specifically targets situations with missing censoring indicators.
  • Regression parameters of the Cox proportional hazards model were estimated.

Main Results:

  • Theoretical investigations demonstrated the efficacy of the proposed Bayesian method.
  • Simulation studies confirmed superior performance compared to existing methods.
  • The method was successfully applied to real-world data from the Orofacial Pain study.

Conclusions:

  • The proposed Bayesian semi-parametric method offers a reliable solution for survival data with missing censoring indicators.
  • This approach enhances the accuracy of regression parameter estimation in large clinical studies.
  • The findings have significant implications for the analysis of complex clinical trial data.